Concentrix Corporation reported $9.97B of revenue over the trailing twelve months, +2.6% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $9.97B (to Q3 2026). Net income: −$2.39B, trailing twelve months to Q3 2026. Free cash flow: $575M, trailing twelve months to Q3 2026. Operating margin: −21%, trailing twelve months to Q3 2026.

CNXCConcentrix Corporation

Technology

$32.99-24% 1Y

$32.99

$20.9652 weeks$46.16

CNXC as reported

Concentrix Corporation reported $9.97B of revenue over the trailing twelve months, +2.6% on the year before. 11 reported series are charted on this page, each one as filed.

$9.97B

Revenue, trailing twelve months · to Q3 2026 · +2.6% against the twelve months before

Net income: −$2.39B
Net income · −856% year on year · trailing twelve months to Q3 2026
Free cash flow: $575M
Free cash flow · +11% year on year · trailing twelve months to Q3 2026
Operating margin: −21%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for CNXC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$9.97B	+2.6%	Q3 2026
Net income	−$2.39B	−856%	Q3 2026
EPS	−$38.42	−914%	Q3 2026
Gross margin	34%	n/a	Q3 2026
Operating margin	−21%	n/a	Q3 2026
Net margin	−24%	n/a	Q3 2026
ROE	−70%	n/a	Q3 2026
ROA	−16%	n/a	Q3 2026
ROIC	−15%	n/a	Q3 2026
Free cash flow	$575M	+11%	Q3 2026
P/E	12.0	n/a	Q3 2025 · 4 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.